Ozenoxacin, a Novel, Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients with Impetigo: Phase III Clinical Trials Pooled Analysis Results

Main Article Content

Nuria Albareda
Noah Rosenberg
Sandra Roth
Ilonka Zsolt
Theodore Rosen
Adelaide A Hebert

Keywords

impetigo, ozenoxacin, antimicrobial, clinical trial

Abstract

Abstract Not Available